
Valium, or diazepam, is a benzodiazepine prescribed for anxiety disorders and, as an add-on, for muscle spasm and some seizure disorders. Taken daily for more than a few weeks, it changes the nervous system it acts on. The brain adapts to the drug’s steady presence at the gamma-aminobutyric acid (GABA) receptor, and that adaptation is physical dependence.
Physical dependence is not addiction. A person who took Valium exactly as prescribed and never chased a high can still be unable to stop without withdrawal, because the dependence lives in the receptors, not in the person’s character. What that person needs is a medical taper, not a program built for a different problem.
The United States Food and Drug Administration (FDA) said as much in 2020, when it required the boxed warning on every benzodiazepine label to be updated to cover physical dependence and withdrawal. The Valium label now states that abrupt discontinuation or rapid dosage reduction after continued use can precipitate acute withdrawal reactions that can be life-threatening, including seizures, and that a gradual taper should be used instead. Call emergency services for a seizure or any other medical emergency during withdrawal.
Unfortunately, “gradual” is often read as two weeks. In Dr. Leeds’ practice in Fort Lauderdale, Florida, a Valium taper is measured in months, sometimes a year or more, and the pace is set by the patient’s symptoms rather than by a calendar.
The Ashton Manual, written by Professor C. Heather Ashton and published online at benzo.org.uk, builds its withdrawal schedules on diazepam. The first reason is its half-life. Table 1 in the Manual’s first chapter lists diazepam at 20 to 100 hours, with an active metabolite lasting up to 200 hours, so each reduction produces a smooth fall in blood level rather than a sudden drop.
The second reason is the tablet. Diazepam comes in 2 mg, 5 mg and 10 mg tablets, and the 2 mg tablet is scored, so it halves cleanly into 1 mg pieces.
The third reason follows from the second. A compounding pharmacy can prepare diazepam as a liquid, which allows decrements far smaller than any tablet permits, and that matters most at the end of a taper, when the last few milligrams are the hardest to leave.
Think of a long-acting drug as a large reservoir with a slow drain. Lower the inflow a little and the level falls gently, and nobody downstream feels a surge.
Who is a Valium taper for? Anyone with physical dependence on a benzodiazepine or a z-drug. A person already taking diazepam simply stabilizes on the current dose, and the reductions begin from there.
A person taking a shorter-acting drug such as Xanax (alprazolam), Klonopin (clonazepam) or Ativan (lorazepam) first makes a crossover taper: the current drug is replaced, step by step, with the diazepam dose that the Manual’s Table 1 lists as roughly equivalent, and the Manual notes that the equivalents vary between individuals. Dr. Leeds explains the reasoning in why the Ashton Manual recommends switching to diazepam before a benzo taper.
Stabilization comes before any reduction. The person settles on a steady daily dose, without rescue doses and without interdose withdrawal, the symptoms that arrive between doses, until they feel level, and only then does the first cut happen. Other prescriptions the person takes, including any other psychiatric medications, affect how the plan is built, so Dr. Leeds reviews the whole list first.
From the first week, the patient keeps a daily record of dose, sleep and the symptoms that matter most to them. That record, not the calendar, decides when the next step happens, and it shows the windows and waves, so a bad week reads as a wave rather than as failure.
Chapter II of the Ashton Manual suggests reducing by up to one tenth of the dose at each decrement, every week or two, with steps that shrink as the dose falls, down to a milligram or less near the end. Its own worked example is a person taking 40 mg of diazepam a day, and the Manual estimates 30 to 60 weeks for that person to reach zero. It adds that many people have taken a year or more, and that whether it takes six, twelve or eighteen months is of little significance.
Those figures describe the shape of the Manual’s example, not a plan for any reader; each person’s dose steps are worked out with their own prescriber. Yet, the shape itself is the lesson. Because each step is a proportion of the current dose, the steps get smaller in milligrams as the dose gets lower, which is what the Maudsley Deprescribing Guidelines call hyperbolic dose reduction: the last milligrams carry a larger share of the drug’s effect than the first, so they are taken away more slowly.
What happens when a step is too big? The person holds. The Valium label itself says that if withdrawal reactions develop, the taper may be paused or the dose returned to the previous level, and the reduction then continued more slowly. In Dr. Leeds’ practice the patient may hold at any dose for as long as they need, and the physician’s job in that moment is to slow things down, never to push.
Some prescribers hand the patient an extra pill for the days when withdrawal bites. Professor Ashton advises against these “escape pills” because they interrupt the smooth decline, and she warns against substituting z-drugs such as zolpidem for the benzodiazepine being tapered. A taper that needs frequent rescue doses is going too fast.
Compounding deserves the same clarity. A compounding pharmacy’s role in a Valium taper is to prepare liquid diazepam, or low-strength capsules, so that reductions can be small; it is not to combine diazepam with other medications in one preparation. Nothing is added to the plan except time.
Even a well-paced taper produces symptoms, and honesty about them is part of consent. Anxiety, poor sleep, irritability, muscle tension, sensory oddities such as tinnitus or tingling, and stomach upset are the common ones, and they tend to rise for a few days after a step and then settle. With diazepam’s long half-life, the interdose withdrawal that troubles people on shorter-acting drugs mostly disappears.
The fact is that benzodiazepine withdrawal can be far harder than outsiders imagine, and it is not weakness that makes it so. Severe symptoms are the signal to hold or step back up, not to press on.
Chapter III of the Ashton Manual describes a post-withdrawal syndrome in some people after years of use, with symptoms lasting months or years after the last dose: anxiety and insomnia easing over the course of a year, and sensory, cognitive and gastrointestinal symptoms sometimes persisting longer. The Valium label itself describes a protracted withdrawal syndrome lasting weeks to more than twelve months. Dr. Leeds draws the line later than the label does: a few weeks of symptoms after the last dose is ordinary withdrawal, and protracted means months and beyond.
Patients often call this benzodiazepine-induced neurological dysfunction (BIND), a name that says what it is: an injured nervous system healing on its own slow schedule. It is not a sign that the taper failed, that the person needs the drug back, or that there was ever a drug problem.
Fortunately, the Manual is plain about the direction of travel: a steady decline in symptoms almost invariably continues after withdrawal, and Professor Ashton found no evidence of permanent damage to the brain or body. A slow taper is the best protection against a long tail.
People searching for Valium detox often picture a facility and a discharge date. What Dr. Leeds offers instead is a gradual, medically supervised taper over months, from the patient’s own home, by telemedicine throughout Florida. It is a concierge practice with one physician, and he works with each patient himself; there is no facility, no required group meeting and no fixed timeline.
Care begins with an informed-consent conversation in the proper order: the risks of continuing and the risks of tapering first, the alternatives including not tapering yet, the exit plan, and the patient’s right to decline or pause at any point. From there the plan follows the Ashton Manual where it helps and the Maudsley principle of smaller steps at lower doses, with liquid diazepam when the tablets no longer cut finely enough. Dr. Leeds describes the method under medically supervised benzodiazepine tapering and the Ashton Manual approach.
For people in Florida who have taken Valium or another benzodiazepine for years and want a physician who will not rush them, Dr. Leeds’ Fort Lauderdale practice offers a slow, patient-directed diazepam taper by telemedicine statewide. Contact Dr. Leeds to ask about a Valium taper.
This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.

Mark Leeds, D.O. is an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida. He helps patients come off benzodiazepines and sleeping pills with a slow, patient-directed taper guided by the Ashton Manual and the Maudsley Deprescribing Guidelines. Physical dependence is not addiction, and a careful taper is measured in months, not days.
Contact Us for expert guidance on safely tapering off benzodiazepines and reclaiming your life.





